索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]罗裕 张奇.复杂高危慢性完全闭塞病变的介入治疗[J].国际心血管病杂志,2020,05:257-259.
点击复制

复杂高危慢性完全闭塞病变的介入治疗(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2020年05期
页码:
257-259
栏目:
综述
出版日期:
2020-10-15

文章信息/Info

Title:
-
作者:
罗裕 张奇
200120 上海,同济大学附属东方医院心内科
Author(s):
-
关键词:
复杂高危冠状动脉粥样硬化性心脏病;  慢性完全闭塞病变;  经皮冠状动脉介入治疗
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2020.05.001
文献标识码:
-
摘要:
复杂、高危、有介入治疗指征的冠状动脉粥样硬化性心脏病患者越来越多,且常合并慢性完全闭塞病变,对介入治疗提出了更高的要求。如何使这些患者从介入治疗中最大获益是临床关注的问题,该文主要介绍了对这类患者介入治疗的策略和围术期的注意事项。
Abstract:
-

参考文献/References

[1] Perera D, Stables R, Clayton T, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study(BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention[J]. Circulation, 2013, 127(2):207-212.
[2] Kirtane AJ, Doshi D, Leon MB, et al. Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention[J]. Circulation, 2016, 134(5):422-431.
[3] Ouweneel DM, Henriques JP. Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations[J]. Heart, 2012, 98(16):1246-1254.
[4] Carlino M, Figini F, Ruparelia N, et al. Predictors of restenosis following contemporary subintimal tracking and reentry technique: the importance of final TIMI flow grade[J]. Catheter Cardiovasc Interv, 2016, 87(3):884-892.
[5] Werner GS, Martin-Yuste V, Hildick-Smith D, et al. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions[J]. Eur Heart J, 2018, 39(26):2484-2493.
[6] Toma A, Gebhard C, Gick M, et al. Survival after percutaneous coronary intervention for chronic total occlusion in elderly patients[J]. EuroIntervention, 2017, 13(2):e228-e235.
[7] Feit F, Brooks MM, Sopko G, et al. Long-term clinical outcome in the bypass angioplasty revascularization investigation registry: comparison with the randomized trial BARI investigators[J]. Circulation, 2000, 101(24):2795-2802.
[8] King SB 3rd, Barnhart HX, Kosinski AS, et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty Versus Surgery Trial Investigators [J]. Am J Cardiol, 1997, 79(11):1453-1459.
[9] Dong W, Li J, Mi H, et al. Relationship between collateral circulation and myocardial viability of 18 F-FDG PET/CT subtended by chronic total occluded coronary arteries[J]. Ann Nucl Med, 2018, 32(3):197-205.
[10] Munoz C, Kunze KP, Neji R, et al. Motion-corrected whole-heart PET-MR for the simultaneous visualisation of coronary artery integrity and myocardial viability: an initial clinical validation[J]. Eur J Nucl Med Mol Imaging, 2018, 45(11):1975-1986.
[11] Alessandrino G, Chevalier B, Lefevre T, et al. A clinical and angiographic scoring system to predict the probability of successful first-attempt percutaneous coronary intervention in patients with total chronic coronary occlusion[J]. JACC Cardiovasc Interv, 2015, 8(12):1540-1548.
[12] Ellis SG, Burke MN, Murad MB, et al. Predictors of successful hybrid-approach chronic total coronary artery occlusion stenting: an improved model with novel correlates[J]. JACC Cardiovasc Interv, 2017, 10(11):1089-1098.
[13] Galassi AR, Boukhris M, Azzarelli S, et al. Percutaneous coronary revascularization for chronic total occlusions: a novel predictive score of technical failure using advanced technologies[J]. JACC Cardiovasc Interv, 2016, 9(9):911-922.
[14] Namazi MH, Serati AR, Vakili H, et al. A novel risk score in predicting failure or success for antegrade approach to percutaneous coronary intervention of chronic total occlusion: antegrade CTO score[J]. Int J Angiol, 2017, 26(2):89-94.
[15] Singh M, Bell MR, Berger PB, et al. Utility of bilateral coronary injections during complex coronary angioplasty [J]. J Invasive Cardiol, 1999, 11(2):70-74.
[16] Tajti P, Burke MN, Karmpaliotis D, et al. Update in the percutaneous management of coronary chronic total occlusions[J]. JACC Cardiovasc Interv, 2018, 11(5):615-625.
[17] Wilson WM, Walsh SJ, Yan AT, et al. Hybrid approach improves success of chronic total occlusion angioplasty [J]. Heart, 2016, 102(18):1486-1493.
[18] Akhondi AB, Lee MS. The use of percutaneous left ventricular assist device in high-risk percutaneous coronary intervention and cardiogenic shock[J]. Rev Cardiovasc Med, 2013, 14(2-4):e144-e149.
[19] Bronchard R, Durand L, Legeai C, et al. Brain-dead donors in extracorporeal membrane oxygenation [J]. Crit Care Med, 2017, 45(10):1734-1741.
[20] Hall AB, Brilakis ES. Hybrid 2.0: Subintimal plaque modification for facilitation of future success in chronic total occlusion percutaneous coronary intervention[J]. Catheter Cardiovasc Interv, 2019, 93(11):199-201.
[21] Passmore MR, Fung YL, Simonova G, et al. Evidence of altered haemostasis in an ovine model of venovenous extra corporeal membrane oxygenation support[J]. Crit Care, 2017, 21(1):191.
[22] Mebazaa A, Tolppanen H, Mueller C, et al. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance[J]. Intensive Care Med, 2016, 42(2):147-163.
[23] Lembo NJ, Hatem R, Karmpaliotis D. Predictive scores of success in CTO PCI: there is no substitute for operator experience and skill [J]. JACC Cardiovasc Interv, 2017, 10(11):1099-1101.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81870202); 浦东新区卫生系统学科带头人培养计划(PWRd2018-06)
通信作者:张奇,E-mail:zhangqnh@hotmail.com
更新日期/Last Update: 2020-10-15